nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Platelet count decreased—Entecavir—hepatitis B	0.0308	0.0308	CcSEcCtD
Meropenem—Sickness—Lamivudine—hepatitis B	0.0306	0.0306	CcSEcCtD
Meropenem—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0195	0.0195	CcSEcCtD
Meropenem—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0188	0.0188	CcSEcCtD
Meropenem—Hepatic failure—Entecavir—hepatitis B	0.0148	0.0148	CcSEcCtD
Meropenem—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0145	0.0145	CcSEcCtD
Meropenem—Sepsis—Telbivudine—hepatitis B	0.0131	0.0131	CcSEcCtD
Meropenem—Blood creatinine increased—Entecavir—hepatitis B	0.0125	0.0125	CcSEcCtD
Meropenem—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0122	0.0122	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0115	0.0115	CcSEcCtD
Meropenem—Neutropenia—Entecavir—hepatitis B	0.0108	0.0108	CcSEcCtD
Meropenem—Renal failure—Entecavir—hepatitis B	0.0101	0.0101	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00985	0.00985	CcSEcCtD
Meropenem—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00984	0.00984	CcSEcCtD
Meropenem—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00976	0.00976	CcSEcCtD
Meropenem—Hepatobiliary disease—Entecavir—hepatitis B	0.0097	0.0097	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00965	0.00965	CcSEcCtD
Meropenem—Abdominal distension—Telbivudine—hepatitis B	0.00952	0.00952	CcSEcCtD
Meropenem—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00947	0.00947	CcSEcCtD
Meropenem—Hepatitis—Entecavir—hepatitis B	0.00921	0.00921	CcSEcCtD
Meropenem—Oedema peripheral—Entecavir—hepatitis B	0.00907	0.00907	CcSEcCtD
Meropenem—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00899	0.00899	CcSEcCtD
Meropenem—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00892	0.00892	CcSEcCtD
Meropenem—Neutropenia—Telbivudine—hepatitis B	0.00884	0.00884	CcSEcCtD
Meropenem—Inflammation—Lamivudine—hepatitis B	0.00875	0.00875	CcSEcCtD
Meropenem—Immune system disorder—Entecavir—hepatitis B	0.00832	0.00832	CcSEcCtD
Meropenem—Renal failure—Telbivudine—hepatitis B	0.00829	0.00829	CcSEcCtD
Meropenem—Neuropathy peripheral—Telbivudine—hepatitis B	0.00826	0.00826	CcSEcCtD
Meropenem—Neuropathy—Lamivudine—hepatitis B	0.00797	0.00797	CcSEcCtD
Meropenem—Hepatobiliary disease—Telbivudine—hepatitis B	0.00797	0.00797	CcSEcCtD
Meropenem—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00771	0.00771	CcSEcCtD
Meropenem—Back pain—Adefovir Dipivoxil—hepatitis B	0.00757	0.00757	CcSEcCtD
Meropenem—Hepatitis—Telbivudine—hepatitis B	0.00757	0.00757	CcSEcCtD
Meropenem—Pharyngitis—Telbivudine—hepatitis B	0.00751	0.00751	CcSEcCtD
Meropenem—Sepsis—Lamivudine—hepatitis B	0.00737	0.00737	CcSEcCtD
Meropenem—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00723	0.00723	CcSEcCtD
Meropenem—Leukopenia—Entecavir—hepatitis B	0.00718	0.00718	CcSEcCtD
Meropenem—Phlebitis—Lamivudine—hepatitis B	0.00716	0.00716	CcSEcCtD
Meropenem—Cough—Adefovir Dipivoxil—hepatitis B	0.00683	0.00683	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00678	0.00678	CcSEcCtD
Meropenem—Injury—Lamivudine—hepatitis B	0.00671	0.00671	CcSEcCtD
Meropenem—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00666	0.00666	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00661	0.00661	CcSEcCtD
Meropenem—Anaphylactic shock—Entecavir—hepatitis B	0.00654	0.00654	CcSEcCtD
Meropenem—Infection—Entecavir—hepatitis B	0.0065	0.0065	CcSEcCtD
Meropenem—Dysgeusia—Telbivudine—hepatitis B	0.00645	0.00645	CcSEcCtD
Meropenem—Nervous system disorder—Entecavir—hepatitis B	0.00642	0.00642	CcSEcCtD
Meropenem—Back pain—Telbivudine—hepatitis B	0.00637	0.00637	CcSEcCtD
Meropenem—Skin disorder—Entecavir—hepatitis B	0.00636	0.00636	CcSEcCtD
Meropenem—Hypoglycaemia—Lamivudine—hepatitis B	0.00632	0.00632	CcSEcCtD
Meropenem—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00626	0.00626	CcSEcCtD
Meropenem—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00625	0.00625	CcSEcCtD
Meropenem—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0062	0.0062	CcSEcCtD
Meropenem—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00609	0.00609	CcSEcCtD
Meropenem—Malaise—Telbivudine—hepatitis B	0.00594	0.00594	CcSEcCtD
Meropenem—Insomnia—Entecavir—hepatitis B	0.00592	0.00592	CcSEcCtD
Meropenem—Somnolence—Entecavir—hepatitis B	0.00582	0.00582	CcSEcCtD
Meropenem—Dyspepsia—Entecavir—hepatitis B	0.00576	0.00576	CcSEcCtD
Meropenem—Cough—Telbivudine—hepatitis B	0.00575	0.00575	CcSEcCtD
Meropenem—Gastrointestinal disorder—Entecavir—hepatitis B	0.00565	0.00565	CcSEcCtD
Meropenem—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00562	0.00562	CcSEcCtD
Meropenem—Chest pain—Telbivudine—hepatitis B	0.00561	0.00561	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00557	0.00557	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00555	0.00555	CcSEcCtD
Meropenem—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00555	0.00555	CcSEcCtD
Meropenem—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00551	0.00551	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00544	0.00544	CcSEcCtD
Meropenem—Abdominal distension—Lamivudine—hepatitis B	0.00536	0.00536	CcSEcCtD
Meropenem—Gastrointestinal pain—Entecavir—hepatitis B	0.00535	0.00535	CcSEcCtD
Meropenem—Nervous system disorder—Telbivudine—hepatitis B	0.00527	0.00527	CcSEcCtD
Meropenem—Thrombocytopenia—Telbivudine—hepatitis B	0.00526	0.00526	CcSEcCtD
Meropenem—Skin disorder—Telbivudine—hepatitis B	0.00522	0.00522	CcSEcCtD
Meropenem—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00522	0.00522	CcSEcCtD
Meropenem—Body temperature increased—Entecavir—hepatitis B	0.00517	0.00517	CcSEcCtD
Meropenem—Abdominal pain—Entecavir—hepatitis B	0.00517	0.00517	CcSEcCtD
Meropenem—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00505	0.00505	CcSEcCtD
Meropenem—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00505	0.00505	CcSEcCtD
Meropenem—Dysuria—Lamivudine—hepatitis B	0.00498	0.00498	CcSEcCtD
Meropenem—Neutropenia—Lamivudine—hepatitis B	0.00498	0.00498	CcSEcCtD
Meropenem—Insomnia—Telbivudine—hepatitis B	0.00486	0.00486	CcSEcCtD
Meropenem—Paraesthesia—Telbivudine—hepatitis B	0.00483	0.00483	CcSEcCtD
Meropenem—Dyspepsia—Telbivudine—hepatitis B	0.00473	0.00473	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00471	0.00471	CcSEcCtD
Meropenem—Asthenia—Entecavir—hepatitis B	0.0047	0.0047	CcSEcCtD
Meropenem—Renal failure—Lamivudine—hepatitis B	0.00467	0.00467	CcSEcCtD
Meropenem—Neuropathy peripheral—Lamivudine—hepatitis B	0.00466	0.00466	CcSEcCtD
Meropenem—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00464	0.00464	CcSEcCtD
Meropenem—Jaundice—Lamivudine—hepatitis B	0.00463	0.00463	CcSEcCtD
Meropenem—Pain—Telbivudine—hepatitis B	0.0046	0.0046	CcSEcCtD
Meropenem—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00458	0.00458	CcSEcCtD
Meropenem—Sweating—Lamivudine—hepatitis B	0.00455	0.00455	CcSEcCtD
Meropenem—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00452	0.00452	CcSEcCtD
Meropenem—Hepatobiliary disease—Lamivudine—hepatitis B	0.00449	0.00449	CcSEcCtD
Meropenem—Epistaxis—Lamivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Meropenem—Diarrhoea—Entecavir—hepatitis B	0.00448	0.00448	CcSEcCtD
Meropenem—Agranulocytosis—Lamivudine—hepatitis B	0.00443	0.00443	CcSEcCtD
Meropenem—Feeling abnormal—Telbivudine—hepatitis B	0.00443	0.00443	CcSEcCtD
Meropenem—Gastrointestinal pain—Telbivudine—hepatitis B	0.0044	0.0044	CcSEcCtD
Meropenem—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00437	0.00437	CcSEcCtD
Meropenem—Dizziness—Entecavir—hepatitis B	0.00433	0.00433	CcSEcCtD
Meropenem—Hepatitis—Lamivudine—hepatitis B	0.00426	0.00426	CcSEcCtD
Meropenem—Abdominal pain—Telbivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Meropenem—Body temperature increased—Telbivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Meropenem—Pharyngitis—Lamivudine—hepatitis B	0.00423	0.00423	CcSEcCtD
Meropenem—Vomiting—Entecavir—hepatitis B	0.00416	0.00416	CcSEcCtD
Meropenem—Rash—Entecavir—hepatitis B	0.00413	0.00413	CcSEcCtD
Meropenem—Dermatitis—Entecavir—hepatitis B	0.00412	0.00412	CcSEcCtD
Meropenem—Headache—Entecavir—hepatitis B	0.0041	0.0041	CcSEcCtD
Meropenem—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00406	0.00406	CcSEcCtD
Meropenem—Erythema multiforme—Lamivudine—hepatitis B	0.00403	0.00403	CcSEcCtD
Meropenem—Rash—Adefovir Dipivoxil—hepatitis B	0.00403	0.00403	CcSEcCtD
Meropenem—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00402	0.00402	CcSEcCtD
Meropenem—Headache—Adefovir Dipivoxil—hepatitis B	0.004	0.004	CcSEcCtD
Meropenem—Nausea—Entecavir—hepatitis B	0.00389	0.00389	CcSEcCtD
Meropenem—Asthenia—Telbivudine—hepatitis B	0.00386	0.00386	CcSEcCtD
Meropenem—Immune system disorder—Lamivudine—hepatitis B	0.00385	0.00385	CcSEcCtD
Meropenem—Chills—Lamivudine—hepatitis B	0.00383	0.00383	CcSEcCtD
Meropenem—Pruritus—Telbivudine—hepatitis B	0.0038	0.0038	CcSEcCtD
Meropenem—Nausea—Adefovir Dipivoxil—hepatitis B	0.00379	0.00379	CcSEcCtD
Meropenem—Erythema—Lamivudine—hepatitis B	0.00371	0.00371	CcSEcCtD
Meropenem—Diarrhoea—Telbivudine—hepatitis B	0.00368	0.00368	CcSEcCtD
Meropenem—Flatulence—Lamivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Meropenem—Tension—Lamivudine—hepatitis B	0.00364	0.00364	CcSEcCtD
Meropenem—Dysgeusia—Lamivudine—hepatitis B	0.00364	0.00364	CcSEcCtD
Meropenem—Nervousness—Lamivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Meropenem—Back pain—Lamivudine—hepatitis B	0.00359	0.00359	CcSEcCtD
Meropenem—Dizziness—Telbivudine—hepatitis B	0.00355	0.00355	CcSEcCtD
Meropenem—Anaemia—Lamivudine—hepatitis B	0.00343	0.00343	CcSEcCtD
Meropenem—Vomiting—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Meropenem—Angioedema—Lamivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Meropenem—Rash—Telbivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Meropenem—Dermatitis—Telbivudine—hepatitis B	0.00339	0.00339	CcSEcCtD
Meropenem—Headache—Telbivudine—hepatitis B	0.00337	0.00337	CcSEcCtD
Meropenem—Malaise—Lamivudine—hepatitis B	0.00335	0.00335	CcSEcCtD
Meropenem—Syncope—Lamivudine—hepatitis B	0.00333	0.00333	CcSEcCtD
Meropenem—Leukopenia—Lamivudine—hepatitis B	0.00332	0.00332	CcSEcCtD
Meropenem—Loss of consciousness—Lamivudine—hepatitis B	0.00326	0.00326	CcSEcCtD
Meropenem—Cough—Lamivudine—hepatitis B	0.00324	0.00324	CcSEcCtD
Meropenem—Nausea—Telbivudine—hepatitis B	0.00319	0.00319	CcSEcCtD
Meropenem—Chest pain—Lamivudine—hepatitis B	0.00316	0.00316	CcSEcCtD
Meropenem—Anxiety—Lamivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Meropenem—Confusional state—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Meropenem—Anaphylactic shock—Lamivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Meropenem—Oedema—Lamivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Meropenem—Infection—Lamivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Meropenem—Shock—Lamivudine—hepatitis B	0.00298	0.00298	CcSEcCtD
Meropenem—Nervous system disorder—Lamivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Meropenem—Thrombocytopenia—Lamivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Meropenem—Skin disorder—Lamivudine—hepatitis B	0.00294	0.00294	CcSEcCtD
Meropenem—Hyperhidrosis—Lamivudine—hepatitis B	0.00293	0.00293	CcSEcCtD
Meropenem—Anorexia—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Meropenem—Hypotension—Lamivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Meropenem—Insomnia—Lamivudine—hepatitis B	0.00274	0.00274	CcSEcCtD
Meropenem—Paraesthesia—Lamivudine—hepatitis B	0.00272	0.00272	CcSEcCtD
Meropenem—Dyspnoea—Lamivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Meropenem—Somnolence—Lamivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Meropenem—Dyspepsia—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Meropenem—Decreased appetite—Lamivudine—hepatitis B	0.00263	0.00263	CcSEcCtD
Meropenem—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00262	0.00262	CcSEcCtD
Meropenem—Constipation—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Meropenem—Pain—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Meropenem—Feeling abnormal—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Meropenem—Gastrointestinal pain—Lamivudine—hepatitis B	0.00248	0.00248	CcSEcCtD
Meropenem—Urticaria—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Meropenem—Body temperature increased—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Meropenem—Abdominal pain—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Meropenem—Hypersensitivity—Lamivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Meropenem—Asthenia—Lamivudine—hepatitis B	0.00217	0.00217	CcSEcCtD
Meropenem—Pruritus—Lamivudine—hepatitis B	0.00214	0.00214	CcSEcCtD
Meropenem—Diarrhoea—Lamivudine—hepatitis B	0.00207	0.00207	CcSEcCtD
Meropenem—Dizziness—Lamivudine—hepatitis B	0.002	0.002	CcSEcCtD
Meropenem—Vomiting—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Meropenem—Rash—Lamivudine—hepatitis B	0.00191	0.00191	CcSEcCtD
Meropenem—Dermatitis—Lamivudine—hepatitis B	0.00191	0.00191	CcSEcCtD
Meropenem—Headache—Lamivudine—hepatitis B	0.0019	0.0019	CcSEcCtD
Meropenem—Nausea—Lamivudine—hepatitis B	0.0018	0.0018	CcSEcCtD
